AZN
Astrazeneca
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: AZN
- PEG Ratio
Based on the most recent data from Jul 13, 2026, AZN's PEG ratio comes in at 0.75. This metric factors in a PE of 25.26 with an earnings growth rate of 33.9%. No notable movement has occurred in the PEG ratio compared to its past four-quarter average.
AZN PEG ratio history
Looking at the last ten years, AZN's PEG ratio has has been around 1.18 on average. At 0.75, today's PE to growth ratio sits 36% below its historical average. Within the last ten years, the Jun 2024 quarter recorded the highest PEG value at 7.81. At 0.03, the Dec 2022 quarter showed the minimum PEG ratio in this period.
Astrazeneca PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.61 | 27.86 | 45.4% |
| 2024 | 1.59 | 28.86 | 18.2% |
| 2023 | 0.43 | 35.08 | 81.1% |
| 2022 | 0.03 | 63.96 | 2,550% |
| 2021 | N/A | 1,456.25 | -96.7% |
| 2020 | 0.3 | 40.98 | 136.9% |
| 2019 | N/A | 96.82 | -39.4% |
| 2018 | N/A | 44.68 | -28.3% |
| 2017 | N/A | 29.28 | -14.4% |
| 2016 | 0.82 | 19.73 | 24.2% |
| 2015 | 0.24 | 30.45 | 127.6% |
| 2014 | N/A | 71.82 | -52% |
| 2013 | N/A | 29.1 | -58.8% |
| 2012 | N/A | 9.55 | -32.1% |
| 2011 | 0.21 | 6.35 | 30.2% |
Astrazeneca PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.87 | 29.39 | 33.9% |
| Dec 2025 | 0.61 | 27.86 | 45.4% |
| Sep 2025 | 0.56 | 25.28 | 44.9% |
| Jun 2025 | 0.91 | 26.12 | 28.6% |
| Mar 2025 | 1.3 | 29.34 | 22.5% |
| Dec 2024 | 1.59 | 28.86 | 18.2% |
| Sep 2024 | 3.61 | 37.19 | 10.3% |
| Jun 2024 | 7.81 | 37.5 | 4.8% |
| Mar 2024 | 0.95 | 33.13 | 35% |
| Dec 2023 | 0.43 | 35.08 | 81.1% |
| Sep 2023 | 0.15 | 35.64 | 242.3% |
| Jun 2023 | 0.08 | 36.06 | 478.1% |
| Mar 2023 | 0.1 | 45.82 | 452.3% |
| Dec 2022 | 0.03 | 63.96 | 2,550% |
| Sep 2022 | N/A | 98.81 | -14% |
AZN average PEG ratio chart
AZN's PEG ratio today is below the 3, 5 and 10-year averages.
PEG comparison
Astrazeneca's PEG of 0.75 is above the Healthcare sector average but below the industry average. Compared to its Healthcare sector average of 0.57, Astrazeneca's PEG is 32% higher.
AZN EPS growth
AZN Price vs fair value
AZN PEG vs peers
Compared to its peers, AZN has a PEG ratio under stock NVS, while above LLY's and BMY's.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| LLY ELI LILLY & Co | 0.33 | $1.11T |
| BMY Bristol Myers Squibb Co | 0.5 | $121.18B |
| AZN Astrazeneca plc | 0.75 | $262.51B |
| NVS Novartis AG | 2.38 | $292.64B |
| PFE Pfizer Inc | N/A | $139.52B |
| MRK Merck & Co Inc | N/A | $306.33B |
| JNJ Johnson & Johnson | N/A | $620.51B |
| BIIB Biogen Inc | N/A | $30.86B |
| ABT Abbott Laboratories | N/A | $160.44B |
Frequently asked questions
What is Astrazeneca's PEG ratio?
AZN shows a PEG ratio of 0.75, per Jul 13, 2026 data.
What is the 3-year average PEG ratio for Astrazeneca (AZN)?
AZN's 3-year PEG ratio average stands at 1.71.
What is the 5-year average PEG ratio for Astrazeneca (AZN)?
AZN's 5-year PEG ratio average stands at 1.36.
What is the highest PEG ratio for AZN?
The Jun 2024 quarter marked the ten years high at 7.81 for AZN's PEG ratio.
How does the current PEG ratio for AZN compare to its historical average?
AZN currently has a PEG ratio 36% below its 10-year average.
How is AZN's PEG ratio calculated (Astrazeneca PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth (YoY TTM). As of Jul 13, 2026, Astrazeneca has a P/E ratio of 25.26. Earnings grew at 33.9% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 0.75. PEG RATIO(0.75) = PE RATIO(25.26) / EPS GROWTH(33.9%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.